1. Home
  2. ANL vs HRTG Comparison

ANL vs HRTG Comparison

Compare ANL & HRTG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Adlai Nortye Ltd.

ANL

Adlai Nortye Ltd.

HOLD

Current Price

$10.20

Market Cap

731.6M

Sector

N/A

ML Signal

HOLD

Logo Heritage Insurance Holdings Inc.

HRTG

Heritage Insurance Holdings Inc.

HOLD

Current Price

$22.51

Market Cap

670.9M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
ANL
HRTG
Founded
2004
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Property-Casualty Insurers
Sector
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
731.6M
670.9M
IPO Year
2022
2014

Fundamental Metrics

Financial Performance
Metric
ANL
HRTG
Price
$10.20
$22.51
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
2
Target Price
$20.00
$33.50
AVG Volume (30 Days)
129.2K
463.9K
Earning Date
04-10-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
214.43
EPS
N/A
1.19
Revenue
N/A
$847,330,000.00
Revenue This Year
$36.02
$7.50
Revenue Next Year
N/A
$6.74
P/E Ratio
N/A
$18.66
Revenue Growth
N/A
3.71
52 Week Low
$0.88
$16.83
52 Week High
$17.25
$31.98

Technical Indicators

Market Signals
Indicator
ANL
HRTG
Relative Strength Index (RSI) 40.94 45.77
Support Level $6.92 $20.73
Resistance Level $12.59 $24.65
Average True Range (ATR) 1.15 0.74
MACD -0.11 0.22
Stochastic Oscillator 26.07 66.56

Price Performance

Historical Comparison
ANL
HRTG

About ANL Adlai Nortye Ltd.

Adlai Nortye Ltd is a clinical-stage company at the forefront of discovering and developing cancer therapies. The company is building a robust pipeline of drug candidates focused on two key areas where it believes it can make a difference RAS-targeting therapies: its is tackling RAS-driven cancers with AN9025, an oral pan-RAS(ON) inhibitor, and AN4035, a CEACAM5-targeting ADC delivering a potent pan-RAS(ON) inhibitor directly to tumors; Next-generation cancer immunotherapies: its candidates, AN8025 (a tri-functional fusion protein of alphaPD-L1 x CD86 variant x LAG3 variant), a T-cell and antigen-presenting cell modulator, and AN4005 (a first-in-class oral small-molecule PD-L1 inhibitor), are designed to activate cancer immunity in novel ways.

About HRTG Heritage Insurance Holdings Inc.

Heritage Insurance Holdings Inc is a regional property and casualty insurance company that offers a variety of personal and commercial insurance products. Through its subsidiaries, Heritage Property & Casualty Insurance, Narragansett Bay Insurance, and Zephyr Insurance, the company issues personal residential property insurance across various states in the U.S. It also offers commercial residential insurance predominantly for its Florida properties. Heritage Insurance manages insurance underwriting, customer services, actuarial analysis, distribution, and claims processing internally. The company operates in Alabama, California, Connecticut, Delaware, Florida, Georgia, Hawaii, Maryland, Massachusetts, Mississippi, New Jersey, New York, North Carolina, Rhode Island, and South Carolina.

Share on Social Networks: